Correlation Between Double Bond and SynCore Biotechnology
Can any of the company-specific risk be diversified away by investing in both Double Bond and SynCore Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Double Bond and SynCore Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Double Bond Chemical and SynCore Biotechnology Co, you can compare the effects of market volatilities on Double Bond and SynCore Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Double Bond with a short position of SynCore Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Double Bond and SynCore Biotechnology.
Diversification Opportunities for Double Bond and SynCore Biotechnology
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Double and SynCore is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Double Bond Chemical and SynCore Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SynCore Biotechnology and Double Bond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Double Bond Chemical are associated (or correlated) with SynCore Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SynCore Biotechnology has no effect on the direction of Double Bond i.e., Double Bond and SynCore Biotechnology go up and down completely randomly.
Pair Corralation between Double Bond and SynCore Biotechnology
Assuming the 90 days trading horizon Double Bond Chemical is expected to under-perform the SynCore Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Double Bond Chemical is 1.27 times less risky than SynCore Biotechnology. The stock trades about -0.18 of its potential returns per unit of risk. The SynCore Biotechnology Co is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 3,685 in SynCore Biotechnology Co on August 30, 2024 and sell it today you would lose (100.00) from holding SynCore Biotechnology Co or give up 2.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Double Bond Chemical vs. SynCore Biotechnology Co
Performance |
| Timeline |
| Double Bond Chemical |
| SynCore Biotechnology |
Double Bond and SynCore Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Double Bond and SynCore Biotechnology
The main advantage of trading using opposite Double Bond and SynCore Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Double Bond position performs unexpectedly, SynCore Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SynCore Biotechnology will offset losses from the drop in SynCore Biotechnology's long position.| Double Bond vs. Coremax Corp | Double Bond vs. Phytohealth Corp | Double Bond vs. Shiny Chemical Industrial | Double Bond vs. YungShin Global Holding |
| SynCore Biotechnology vs. Shan Loong Transportation Co | SynCore Biotechnology vs. STL Technology Co | SynCore Biotechnology vs. Chung Hwa Food | SynCore Biotechnology vs. United Radiant Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |